Overview
| MDL | MFCD20526529 |
|---|
| Molecular Weight | 629.81 |
|---|
| Molecular Formula | C32H47N5O6S |
|---|
| SMILES | O=C(N1CCN(C([C@@H](NS(=O)(C2=C(C(C)C)C=C(C(C)C)C=C2C(C)C)=O)CC3=CC=CC(C(NO)=N)=C3)=O)CC1)OCC |
|---|
For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
| 1 mg | 5 mg | 10 mg |
| 1 mM | 1.5878 mL | 7.9389 mL | 15.8778 mL |
| 5 mM | 0.3176 mL | 1.5878 mL | 3.1756 mL |
| 10 mM | 0.1588 mL | 0.7939 mL | 1.5878 mL |
| 50 mM | 0.0318 mL | 0.1588 mL | 0.3176 mL |
Description
Upamostat (WX-671), a novel inhibitor by inhibiting the urokinase-type plasminogen activator (uPA) system.
Targets
| serine protease urokinase (uPA) [1] |